Market Overview

Benzinga's Top #PreMarket Gainers


Celladon Corporation (NASDAQ: CLDN) shares gained 11.45% to $21.90 in the pre-market trading session. Roth Capital initiated coverage on Celladon with a Buy rating.

Roundy's, Inc. (NYSE: RNDY) shares rose 10.95% to $4.46 in pre-market trading after the company reported stronger-than-expected results for the fourth quarter.

Pharmacyclics Inc. (NASDAQ: PCYC) shares surged 9.87% to $253.22 in pre-market trading after AbbVie (NYSE: ABBV) announced its plans to acquire Pharmacyclics for $261.25 per share in cash and stock.

Navidea Biopharmaceuticals, Inc (NYSE: NAVB) shares climbed 9.82% to $1.79 in pre-market trading on Q4 results. Navidea Biopharmaceuticals reported a Q3 loss of $0.08 per share on revenue of $2.2 million.

Arrowhead Research Corp. (NASDAQ: ARWR) gained 9.19% to $8.20 in pre-market trading after the company reported the acquisition of Novartis' entire RNAi research and development portfolio and associated assets.


Related Articles (RNDY + CLDN)

View Comments and Join the Discussion!

Posted-In: Premarket MoversNews Pre-Market Outlook Markets Movers